A step in the right direction, but one size might not fit all.
Simon
S
Noble
D000970:Antineoplastic Agents / Q000009:adverse effects; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D017762:Nadroparin / Q000627:therapeutic use*; D010190:Pancreatic Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D013923:Thromboembolism / Q000209:etiology* / Q000517:prevention & control*
D000970:Antineoplastic Agents; D005343:Fibrinolytic Agents; D017762:Nadroparin